NIH-funded research NIH-funded research

PediCODE: A Biorepository and Consortium for CoDE - Congenital Diarrhea and Enteropathy

Official title: COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository

Funded at University of California Los Angeles · NIH-11620095 · Data updated 2026-11-12

A nationwide effort to collect clinical data and patient-derived samples to uncover the genetic causes of congenital diarrhea and enteropathy and to build a resource that helps researchers study these diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 15, 2019
Project endAugust 31, 2029
Funding year2026
Award (this year)$341,950
NIH project number3RC2DK118640-08S1
Project IDNIH-11620095 on NIH RePORTER

Who could benefit from this research

Could help

Children and adolescents diagnosed with Congenital Diarrhea and Enteropathy or suspected monogenic CoDE disorders, and their biological samples for biorepository contribution.

Less likely to help

Individuals without CoDE or without enrollment in a related center's biorepository contributions are unlikely to benefit directly from this grant.

What this research studies

This project creates a multi-center consortium and biorepository to identify monogenic causes of Congenital Diarrhea and Enteropathy (CoDE) by collecting detailed patient data, genes, tissues, and patient-derived cells. Researchers will develop protein-interactome and single-cell transcriptomic data from biopsies and build computational tools to analyze these data. The initiative will enroll CoDE patients, expand the clinical database, and enable mechanistic studies of both known and novel CoDE genes. The resulting resource is intended to accelerate understanding and future therapeutic experiments for CoDE disorders.

Why it matters

Potential benefit: If successful, patients with CoDE could receive faster genetic diagnosis, a deeper understanding of disease mechanisms, and access to future targeted therapies or clinical studies.

How similar studies have gone: Previous efforts to establish disease-focused biorepositories and multi-center cohorts have accelerated discovery in rare genetic disorders, though CoDE-specific work is emerging.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Martin, Martin G — University of California Los Angeles
  • Study coordinator: Martin, Martin G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.